Send your comments and tips to email@example.com
Beth Israel Deaconess Medical Ctr.
Boston Medical Center
Brigham and Women's Hospital
Cambridge Health Alliance
Caritas St. Elizabeth's Medical Ctr.
Children's Hospital Boston
Dana-Farber Cancer Institute
Joslin Diabetes Center
Mass. General Hospital
Mass. Health Law
New England Baptist Hospital
Short White Coat
Tufts-New England Medical Center
UMass Memorial Medical Center
University of Massachusetts
VA Medical Centers
A Healthy Blog
Running A Hospital
Nature Network Boston
SciBos - Corie Lok's blog
Nurse at small
Dr. Gwenn Is In
Healthy Children blog
Other Globe Blogs
Elizabeth Cooney is a health reporter for the Worcester Telegram & Gazette.
Boston Globe Health and Science staff:
Karen Weintraub, Deputy Health and Science Editor, and Gideon Gil, Health and Science Editor.
Short White Coat blogger Ishani Ganguli
Short White Coat blogger Jennifer Srygley
Friday, August 10, 2007
Update on Harvard stem cell scientist
Here's an update from Harvard stem cell scientist Kevin C. Eggan on a report in today's New York Times –- denied earlier today by a Harvard spokesman -- that he is delaying a move to Kansas City because of political opposition in Missouri to human embryonic stem cell research.
"Our contracts say that advancement in the institute would be tied to moving to Kansas City if the political situation improved," Eggan said. "It was always very much on the table."
Even though Missouri voters approved a constitutional amendment in November to allow stem cell research, state legislators have proposed many bills that would limit any research on human embryonic stem cells.
"The political situation is anything but clear," Eggan said.
Jim and Virginia Stowers of Kansas City, who have delayed a $300 million expansion of their Stowers Institute for Medical Research there, started supporting Eggan and Cowan because they thought Missouri would ban stem cell research.
If the climate for stem cell research changes in Missouri, Eggan and his lab colleagues will have a decision to make.
"It's certainly something we would have to seriously consider," he said.